Any current/future new fundraising through debt or equity?

The management did not explicitly mention any ongoing or planned fundraising through debt or equity in the Q4 FY '25 earnings call. Discussions are underway related to reducing promoter holding to comply with SEBI's 75% minimum requirement by May 31st, which may involve placing shares via permissible mechanisms; however, detailed plans are not disclosed yet. The company had raised QIP funds in the past and has deployed them effectively, contributing to margin improvement. No specific new debt or equity fundraising announcements were made during the call or in the available transcript.

Any current/future capex/capital investment/strategic investment?

Aether Industries is expanding its R&D center at Site-1, doubling the R&D capacity to support the CRAMS business model. Site-3++ is being developed and dedicated to a key client under the Contract/Exclusive Manufacturing (CEM) business model, with production expected to start by end of Q3 FY 2026. Site-4 has been successfully commercialized and is operating at full capacity. Site-5 expansion is progressing, with two production blocks on track for commissioning by December 2025; additional 15 acres acquired at Site-5 totaling 46 acres, earmarked for large customers like Baker Hughes. The compan

Future growth expectations in sales/revenue/volumes?

Aether Industries achieved 34% volume growth in FY 2025 compared to FY 2024, with volumes rising 21% quarter-on-quarter in Q4 FY25. Pricing has remained stable over the past six months, supporting strong demand. The company aims to shift revenue mix to 70% from CRAMS and CEM business models and 30% from large-scale manufacturing, indicating growth in higher-margin contract manufacturing segments. Site-4 has been commercialized with full production and is expected to ramp up further in FY26 and FY27. Site-3++ is dedicated to a key client under a CEM model, with production anticipated to start b

Future growth expectations in earnings/operating earnings/profits/EPS?

Aether Industries expects to maintain or grow EBITDA margins around 29%-30% in the near term, with gradual improvement beyond that. The company aims for PAT margins to continue at about 18%, supported by growth in Contract Manufacturing (CEM) and CRAMS businesses. Revenue growth is anticipated to be robust, with management indicating the possibility of an 18%-20% CAGR over the next 3-4 years or faster, driven by new customers and contracts. Expansion of R&D capacity suggests potential increases in innovation and value-added products. New capacities at Site-3++, Site-4, and Site-5 are expected

Current/ Expected Orderbook/ Pending Orders?

The contract with Baker Hughes is being finalized, and once finalized, orders are expected to follow immediately (Page 12). No specific current order book size or value is mentioned publicly; discussions indicate a pipeline of strategic partnerships and contracts being developed, especially in CRAMS and CEM businesses (Page 11). Site-4 has started commercial supplies from April with existing confirmed orders (Page 13). Site-3++ is dedicated to a CEM business model with production anticipated to begin by end of Q3 FY 2026, indicating upcoming order fulfillment capacity (Page 4). Management refr

IN US

Sale is live|00:00:00left today

Aether Industries LtdQ1 FY25Chemicals & Petrochemicals

Aether Industries Ltd Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,325P/E: 65.2Market Cap: ₹14.7K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→Aether Industries achieved 34% volume growth in FY 2025 compared to FY 2024, with volumes rising 21% quarter-on-quarter in Q4 FY25.
→Pricing has remained stable over the past six months, supporting strong demand.
→The company aims to shift revenue mix to 70% from CRAMS and CEM business models and 30% from large-scale manufacturing, indicating growth in higher-margin contract manufacturing segments.
→Site-4 has been commercialized with full production and is expected to ramp up further in FY26 and FY27.
→Site-3++ is dedicated to a key client under a CEM model, with production anticipated to start by end of Q3 FY26.
→Site-5 expansion is advancing, with first two production blocks expected to commission by December 2025.
→Management is optimistic about continued growth driven by strategic partnerships, increasing CRAMS and CEM contracts, and the favorable global chemical industry environment.

Margin guidance

Category 3

→Aether Industries expects to maintain or grow EBITDA margins around 29%-30% in the near term, with gradual improvement beyond that.
→The company aims for PAT margins to continue at about 18%, supported by growth in Contract Manufacturing (CEM) and CRAMS businesses.
→Revenue growth is anticipated to be robust, with management indicating the possibility of an 18%-20% CAGR over the next 3-4 years or faster, driven by new customers and contracts.
→Expansion of R&D capacity suggests potential increases in innovation and value-added products.
→New capacities at Site-3++, Site-4, and Site-5 are expected to contribute to growth, with some production starting by Q3 FY26 and further ramp-up by FY27.
→Focus on increasing contribution from CRAMS and CEM to 70% of revenues supports higher-margin growth.
→Management is cautiously optimistic but does not give explicit forward numerical guidance.

3 more insights locked — sign up free to unlock

Fundraise plans

→The management did not explicitly mention any ongoing or planned fundraising through debt or equity in the Q4 FY '25 earnings call.
→Discussions are underway related to reducing promoter holding to comply with SEBI's 75% minimum requirement by May 31st, which may involve placing shares via permissible mechanisms; however, detailed plans are not disclosed yet.
→The company had raised QIP funds in the past and has deployed them effectively, contributing to margin improvement.
→No specific new debt or equity fundraising announcements were made during the call or in the available transcript.

Order book

Yes

→The contract with Baker Hughes is being finalized, and once finalized, orders are expected to follow immediately (Page 12).
→No specific current order book size or value is mentioned publicly; discussions indicate a pipeline of strategic partnerships and contracts being developed, especially in CRAMS and CEM businesses (Page 11).
→Site-4 has started commercial supplies from April with existing confirmed orders (Page 13).
→Site-3++ is dedicated to a CEM business model with production anticipated to begin by end of Q3 FY 2026, indicating upcoming order fulfillment capacity (Page 4).
→Management refrained from disclosing specific contract details or product names due to confidentiality but indicated robust order inflow aligned with growth in Contract Manufacturing and CRAMS segments (Page 10).

Capex plans

Yes

→Aether Industries is expanding its R&D center at Site-1, doubling the R&D capacity to support the CRAMS business model.
→Site-3++ is being developed and dedicated to a key client under the Contract/Exclusive Manufacturing (CEM) business model, with production expected to start by end of Q3 FY 2026.
→Site-4 has been successfully commercialized and is operating at full capacity.
→Site-5 expansion is progressing, with two production blocks on track for commissioning by December 2025; additional 15 acres acquired at Site-5 totaling 46 acres, earmarked for large customers like Baker Hughes.
→The company plans to invest significantly and strategically in R&D, aiming to increase R&D spend possibly to 10%-12% of revenues.
→Solar power initiatives are expanding, saving Rs. 188 million in FY 25 and reducing electricity costs at production sites.
→Internal goal of sustaining ~30% EBITDA margins while scaling operations through these expansions.

How does Aether Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Aether Industries Ltd

Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Aether Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio